Actively Recruiting
The Association of Psychological Stress with the Efficacy of Neoadjuvant Therapy in Breast Cancer
Led by Shengjing Hospital · Updated on 2024-11-15
840
Participants Needed
1
Research Sites
110 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to explore the relationship between psychological stress and the therapeutic response in breast cancer patients who have received standard neoadjuvant chemotherapy.
CONDITIONS
Official Title
The Association of Psychological Stress with the Efficacy of Neoadjuvant Therapy in Breast Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Histological and/or cytological diagnosis of breast cancer
- Treatment-naive patients
- Planned to receive standard neoadjuvant therapy
- Eastern Cooperative Oncology Group (ECOG) performance status of 0-1
- At least one measurable lesion based on RECIST v1.1 criteria
- Provided informed consent and agreed to participate in the study
You will not qualify if you...
- Breast cancer not confirmed by histological or cytological examinations
- Breast cancer conditions not undergoing neoadjuvant therapy
- Presence of other malignant tumors
- Acute or chronic psychiatric disorders with antidepressant or anti-anxiety treatment within the past month
- Participation in other clinical trials within the past month, except observational or non-interventional studies
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Shengjing Hospital of China Medical University
Shenyang, Liaoning, China, 110004
Actively Recruiting
Research Team
L
Liu Hua, Ph. D
CONTACT
L
Liu Cai Gang, Ph. D
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here